Generated: December 11, 2017
DrugPatentWatch Database Preview
Methamphetamine hydrochloride - Generic Drug Details
« Back to Dashboard
What are the generic sources for methamphetamine hydrochloride and what is the scope of methamphetamine hydrochloride freedom to operate?
is the generic ingredient in three branded drugs marketed by Recordati Rare, Teva, Able, Mayne Pharma Inc, Rexar, and West-ward Pharms Int, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.
There are six drug master file entries for methamphetamine hydrochloride. Four suppliers are listed for this compound.
Summary for methamphetamine hydrochloride
Pharmacology for methamphetamine hydrochloride
Medical Subject Heading (MeSH) Categories for methamphetamine hydrochloride
|Recordati Rare||DESOXYN||methamphetamine hydrochloride||TABLET, EXTENDED RELEASE;ORAL||005378-004||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva||METHAMPHETAMINE HYDROCHLORIDE||methamphetamine hydrochloride||TABLET;ORAL||086359-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mayne Pharma Inc||METHAMPHETAMINE HYDROCHLORIDE||methamphetamine hydrochloride||TABLET;ORAL||091189-001||Apr 21, 2010||AA||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva||METHAMPEX||methamphetamine hydrochloride||TABLET;ORAL||083889-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|West-ward Pharms Int||METHAMPHETAMINE HYDROCHLORIDE||methamphetamine hydrochloride||TABLET;ORAL||203846-001||Nov 17, 2015||AA||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Recordati Rare||DESOXYN||methamphetamine hydrochloride||TABLET, EXTENDED RELEASE;ORAL||005378-005||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Able||METHAMPHETAMINE HYDROCHLORIDE||methamphetamine hydrochloride||TABLET;ORAL||040529-001||Feb 25, 2004||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Rexar||METHAMPHETAMINE HYDROCHLORIDE||methamphetamine hydrochloride||TABLET;ORAL||084931-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Recordati Rare||DESOXYN||methamphetamine hydrochloride||TABLET, EXTENDED RELEASE;ORAL||005378-003||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Recordati Rare||DESOXYN||methamphetamine hydrochloride||TABLET;ORAL||005378-002||Approved Prior to Jan 1, 1982||AA||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.